Peptides as therapy of autoimmune disease.
Fathman
C G
CG
Stanford University School of Medicine, Division of Immunology and Rheumatology, California 94305-5111.
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D001667:Binding, Competitive; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000628:therapy; D006649:Histocompatibility Antigens; D006801:Humans; D007167:Immunotherapy; D010455:Peptides / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell
D006649:Histocompatibility Antigens; D010455:Peptides; D011948:Receptors, Antigen, T-Cell